When stem cells meet COVID-19: recent advances, challenges and future perspectives

被引：0
作者：
Shasha Li
Hecheng Zhu
Ming Zhao
Weidong Liu
Lei Wang
Bin Zhu
Wen Xie
Cong Zhao
Yao Zhou
Caiping Ren
Hui Liu
Xingjun Jiang
机构：
[1] Central South University,Cancer Research Institute, Department of Neurosurgery, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
[2] Changsha Kexin Cancer Hospital,The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, School of Basic Medicine
[3] Central South University,School of Ophthalmology and Optometry and Eye Hospital
[4] Wenzhou Medical University,Department of Neurosurgery, Xiangya Hospital
[5] Central South University,undefined
来源：
Stem Cell Research & Therapy | / 13卷
关键词：
COVID-19; SARS-CoV-2; Stem cell threapy; MSCs; Organoid models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory coronavirus 2 is currently spreading throughout the world with a high rate of infection and mortality and poses a huge threat to global public health. COVID-19 primarily manifests as hypoxic respiratory failure and acute respiratory distress syndrome, which can lead to multiple organ failure. Despite advances in the supportive care approaches, there is still a lack of clinically effective therapies, and there is an urgent need to develop novel strategies to fight this disease. Currently, stem cell therapy and stem cell-derived organoid models have received extensive attention as a new treatment and research method for COVID-19. Here, we discuss how stem cells play a role in the battle against COVID-19 and present a systematic review and prospective of the study on stem cell treatment and organoid models of COVID-19, which provides a reference for the effective control of the COVID-19 pandemic worldwide.
引用
收藏
相关论文
共 586 条
[51]  
Mahmood A(2015)The immunomodulatory function of mesenchymal stem cells: mode of action and pathways Ann N Y Acad Sci 1351 1-51
[52]  
Srivastava A(2019)Mesenchymal stem cell migration and tissue repair Cells 8 2173-152
[53]  
Chan JF(2019)Mesenchymal Stem Cells for Regenerative Medicine Cells 8 216-2645
[54]  
To KK(2019)The pros and cons of mesenchymal stem cell-based therapies Cell Transplant 28 e71-170
[55]  
Tse H(2019)The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine Stem Cell Res Ther 10 172-216
[56]  
Jin DY(2017)Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine Stem Cells Transl Med 6 361-1029
[57]  
Yuen KY(2020)Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Aging Dis 11 291-402
[58]  
Su S(2020)Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use Pain Physician 23 207-2191
[59]  
Wong G(2020)Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial Signal Transduct Target Ther 5 57-62
[60]  
Shi W(2020)Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells Stem Cell Res Ther 11 664-4001
12345678910